Skip Navigation

This Article
Right arrow Full Text (PDF)
Right arrow E-Letters: Submit a response to the article
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by CARSON, R. J.
Right arrow Articles by REYNOLDS, F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by CARSON, R. J.
Right arrow Articles by REYNOLDS, F.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

British Journal of Anaesthesia, 1992, Vol. 69, No. 2 150-153
© 1992 The Board of Management and Trustees of the British Journal of Anaesthesia

research-article

ELIMINATION OF BUPIVACAINE AND PETHIDINE FROM THE RABBIT FETO-PLACENTAL UNIT

R. J. CARSON, B.SC., PH.D.* and F. REYNOLDS, M.D., F.R.C.ANAES.1

Anaesthetic Unit, St. Thomas' Hospital Lambeth Palace Road, London SE1 7EH

1Correspondence to F. R.

Bupivacaine 12.5 mg and pethidine 12.5 mg were administered as an i.v. infusion over 80 min in 15 near-term pregnant New Zealand white rabbits. After the infusion, pups were removed via individual hysterotomies every 30 min. Bupivacaine and pethidine were measured by gas chromatography in amniotic fluid, placenta, fetal plasma, fetal brain and maternal plasma, sampled as each fetal sac was opened. Pethidine was cleared from all compartments more rapidly than bupivacaine and for both drugs elimination rates were maternal plasma placenta < amniotic fluid < fetal brain < fetal plasma. Concentrations of both drugs in fetal plasma correlated significantly only with those in fetal brain and not with those in maternal plasma, placenta or amniotic fluid, while there were positive correlations between the last three compartments. Nested analysis of covariance showed that only maternal plasma and placental concentrations of the two drugs decreased significantly with time. Maternal plasma half-lives for pethidine and bupivacaine were 1.0 and 2.0 h, and placenta/ half- lives 1.9 and 2.5 h, respectively. The apparent fetal plasma half-life of pethidine was 9.9 h while there was apparently no net elimination of bupivacaine from fetal plasma.

*Present address: Department of Biomedical Science, Wolver-hampton Polytechnic, Lichfield Street, Wolverhampton WV1.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?




Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.